Zacks Research Comments on Teleflex's Q2 Earnings (NYSE:TFX)

Teleflex Incorporated (NYSE:TFX - Free Report) - Stock analysts at Zacks Research cut their Q2 2026 earnings per share (EPS) estimates for shares of Teleflex in a report released on Tuesday, June 24th. Zacks Research analyst R. Department now expects that the medical technology company will post earnings per share of $3.91 for the quarter, down from their prior forecast of $3.93. The consensus estimate for Teleflex's current full-year earnings is $13.98 per share. Zacks Research also issued estimates for Teleflex's FY2027 earnings at $15.09 EPS.

Other research analysts have also issued research reports about the stock. Wall Street Zen upgraded shares of Teleflex from a "hold" rating to a "buy" rating in a research note on Saturday, June 21st. Bank of America downgraded Teleflex from a "neutral" rating to an "underperform" rating and cut their target price for the company from $235.00 to $140.00 in a research report on Tuesday, March 4th. Morgan Stanley reduced their target price on Teleflex from $191.00 to $173.00 and set an "overweight" rating for the company in a research note on Monday, May 5th. Mizuho set a $155.00 price target on Teleflex in a research note on Wednesday, April 16th. Finally, Royal Bank Of Canada cut their price objective on Teleflex from $150.00 to $145.00 and set a "sector perform" rating on the stock in a report on Friday, May 2nd. One research analyst has rated the stock with a sell rating, eight have assigned a hold rating and three have given a buy rating to the company. According to MarketBeat, the stock currently has a consensus rating of "Hold" and an average price target of $164.63.

Teleflex Stock Performance

Shares of Teleflex stock opened at $119.45 on Friday. The company has a 50 day moving average price of $124.61 and a 200 day moving average price of $148.29. The firm has a market capitalization of $5.28 billion, a P/E ratio of 37.68, a PEG ratio of 1.87 and a beta of 1.10. The company has a quick ratio of 1.32, a current ratio of 2.28 and a debt-to-equity ratio of 0.44. Teleflex has a 52 week low of $115.94 and a 52 week high of $249.91.

Teleflex (NYSE:TFX - Get Free Report) last released its quarterly earnings results on Thursday, May 1st. The medical technology company reported $2.91 EPS for the quarter, beating analysts' consensus estimates of $2.88 by $0.03. Teleflex had a return on equity of 14.73% and a net margin of 4.96%. The company had revenue of $700.67 million during the quarter, compared to analysts' expectations of $699.37 million. During the same period last year, the business posted $3.21 earnings per share. The firm's revenue was down 5.0% compared to the same quarter last year.

Teleflex Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Monday, June 16th. Stockholders of record on Tuesday, May 20th were issued a $0.34 dividend. The ex-dividend date of this dividend was Tuesday, May 20th. This represents a $1.36 annualized dividend and a dividend yield of 1.14%. Teleflex's dividend payout ratio (DPR) is presently 42.90%.

Institutional Trading of Teleflex

A number of hedge funds have recently modified their holdings of the stock. Sanctuary Advisors LLC lifted its holdings in Teleflex by 28.2% in the fourth quarter. Sanctuary Advisors LLC now owns 6,251 shares of the medical technology company's stock valued at $1,143,000 after acquiring an additional 1,374 shares during the period. Fjarde AP Fonden Fourth Swedish National Pension Fund increased its holdings in shares of Teleflex by 43.0% during the 4th quarter. Fjarde AP Fonden Fourth Swedish National Pension Fund now owns 11,644 shares of the medical technology company's stock valued at $2,072,000 after purchasing an additional 3,500 shares in the last quarter. IFP Advisors Inc lifted its stake in shares of Teleflex by 238.5% in the 4th quarter. IFP Advisors Inc now owns 308 shares of the medical technology company's stock valued at $55,000 after purchasing an additional 217 shares during the period. Bryn Mawr Capital Management LLC purchased a new stake in Teleflex during the fourth quarter worth $213,000. Finally, Proficio Capital Partners LLC acquired a new stake in Teleflex during the fourth quarter valued at $3,297,000. Hedge funds and other institutional investors own 95.62% of the company's stock.

About Teleflex

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.